294 related articles for article (PubMed ID: 18849421)
1. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation.
Mena A; Smith EE; Burns JL; Speert DP; Moskowitz SM; Perez JL; Oliver A
J Bacteriol; 2008 Dec; 190(24):7910-7. PubMed ID: 18849421
[TBL] [Abstract][Full Text] [Related]
2. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
[TBL] [Abstract][Full Text] [Related]
3. Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistance.
Oliver A; Mena A
Clin Microbiol Infect; 2010 Jul; 16(7):798-808. PubMed ID: 20880409
[TBL] [Abstract][Full Text] [Related]
4. Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.
López-Causapé C; Rojo-Molinero E; Mulet X; Cabot G; Moyà B; Figuerola J; Togores B; Pérez JL; Oliver A
PLoS One; 2013; 8(8):e71001. PubMed ID: 23951065
[TBL] [Abstract][Full Text] [Related]
5. Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.
Maciá MD; Blanquer D; Togores B; Sauleda J; Pérez JL; Oliver A
Antimicrob Agents Chemother; 2005 Aug; 49(8):3382-6. PubMed ID: 16048951
[TBL] [Abstract][Full Text] [Related]
6. The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants.
Oliver A; Baquero F; Blázquez J
Mol Microbiol; 2002 Mar; 43(6):1641-50. PubMed ID: 11952911
[TBL] [Abstract][Full Text] [Related]
7. Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infections.
Warren AE; Boulianne-Larsen CM; Chandler CB; Chiotti K; Kroll E; Miller SR; Taddei F; Sermet-Gaudelus I; Ferroni A; McInnerney K; Franklin MJ; Rosenzweig F
Infect Immun; 2011 Dec; 79(12):4802-18. PubMed ID: 21930755
[TBL] [Abstract][Full Text] [Related]
8. Coexistence and within-host evolution of diversified lineages of hypermutable Pseudomonas aeruginosa in long-term cystic fibrosis infections.
Feliziani S; Marvig RL; Luján AM; Moyano AJ; Di Rienzo JA; Krogh Johansen H; Molin S; Smania AM
PLoS Genet; 2014 Oct; 10(10):e1004651. PubMed ID: 25330091
[TBL] [Abstract][Full Text] [Related]
9. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
[TBL] [Abstract][Full Text] [Related]
10. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
[TBL] [Abstract][Full Text] [Related]
11. Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.
Luján AM; Maciá MD; Yang L; Molin S; Oliver A; Smania AM
PLoS One; 2011; 6(11):e27842. PubMed ID: 22114708
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
[TBL] [Abstract][Full Text] [Related]
13. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
Hogardt M; Hoboth C; Schmoldt S; Henke C; Bader L; Heesemann J
J Infect Dis; 2007 Jan; 195(1):70-80. PubMed ID: 17152010
[TBL] [Abstract][Full Text] [Related]
14. Gene Loss and Acquisition in Lineages of Pseudomonas aeruginosa Evolving in Cystic Fibrosis Patient Airways.
Gabrielaite M; Johansen HK; Molin S; Nielsen FC; Marvig RL
mBio; 2020 Oct; 11(5):. PubMed ID: 33109761
[TBL] [Abstract][Full Text] [Related]
15. Pseudomonas aeruginosa syntrophy in chronically colonized airways of cystic fibrosis patients.
Qin X; Zerr DM; McNutt MA; Berry JE; Burns JL; Kapur RP
Antimicrob Agents Chemother; 2012 Nov; 56(11):5971-81. PubMed ID: 22964251
[TBL] [Abstract][Full Text] [Related]
16. Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis.
Montanari S; Oliver A; Salerno P; Mena A; Bertoni G; Tümmler B; Cariani L; Conese M; Döring G; Bragonzi A
Microbiology (Reading); 2007 May; 153(Pt 5):1445-1454. PubMed ID: 17464058
[TBL] [Abstract][Full Text] [Related]
17. Evolutionary insight from whole-genome sequencing of Pseudomonas aeruginosa from cystic fibrosis patients.
Marvig RL; Sommer LM; Jelsbak L; Molin S; Johansen HK
Future Microbiol; 2015; 10(4):599-611. PubMed ID: 25865196
[TBL] [Abstract][Full Text] [Related]
18. Convergent evolution and adaptation of Pseudomonas aeruginosa within patients with cystic fibrosis.
Marvig RL; Sommer LM; Molin S; Johansen HK
Nat Genet; 2015 Jan; 47(1):57-64. PubMed ID: 25401299
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
[TBL] [Abstract][Full Text] [Related]
20. Molecular Epidemiology of Mutations in Antimicrobial Resistance Loci of Pseudomonas aeruginosa Isolates from Airways of Cystic Fibrosis Patients.
Greipel L; Fischer S; Klockgether J; Dorda M; Mielke S; Wiehlmann L; Cramer N; Tümmler B
Antimicrob Agents Chemother; 2016 Nov; 60(11):6726-6734. PubMed ID: 27572404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
